Mesoblast Limited (MSB.XA) Deep Dive Video

First FDA-approved off-the-shelf MSC therapy turns Mesoblast into a commercial biotech—now the upside hinges on executing two blockbuster Phase 3 shots on goal without CMC or dilution missteps.